Table 2.
Breathing for Life Trial Study Procedures
| Visit 1 (Control group) | Visit 1 (FENO group) | Follow-up Visits (FENO group) | |
|---|---|---|---|
| Time frame | 12–22+6 weeks gestation | 12–22+6 weeks gestation | Every 3–6 weeks |
| Consent | ✓ | ✓ | |
| Inclusion/exclusion | ✓ | ✓ | |
| Other illnesses | ✓ | ✓ | |
| Asthma diagnosis | ✓ | ✓ | |
| Randomisation | ✓ | ✓ | |
| Demographics | ✓ | ✓ | |
| Height & weight | ✓ | ✓ | |
| Smoking questions | ✓ | ✓ | ✓ |
| Ethnicity | ✓ | ✓ | |
| Occupation | ✓ | ✓ | |
| FENO | ✓ | ✓ | |
| Spirometry | ✓ | ✓ | ✓ |
| ECO | ✓ | ✓ | ✓ |
| ACQ | ✓ | ✓ | |
| Asthma history | ✓ | ✓ | |
| Current medications | ✓ | ✓ | ✓ |
| Current symptoms | ✓ | ✓ | ✓ |
| Self-management education | ✓ | ✓ | ✓ |
| Written action plan | ✓ | ||
| FENO treatment algorithm | ✓ | ✓ (every 2nd visit) | |
| Medication supply | ✓ | ✓ | |
| Written information provided | ✓ | ✓ | |
| Letter to GP/primary carer | ✓ | ✓ |